The Unit for Liver Diseases

The main research projects of the Liver Unit focus on prevention and treatment of viral hepatitis, primary liver tumors and liver transplantation, currently involved in development of a new vaccine against hepatitis B. This vaccine has been instrumental in the study for adoptive transfer of immunity in patients undergoing stem cell or bone marrow transplantation. Scientist in the unit are leading a collaborative pilot study to evaluate the role of hepatitis A immunization post-exposure (instead of immune serum globulin). The Liver Unit is also involved in testing of a number of new anti-viral drugs against hepatitis B and C virus infections, as well as against primary liver cancer.

Contact Info

Contact Person Prof. Daniel Shouval, M.D., Director
Phone 972-2-6776449
Fax 972-2-6777394